Total Drugs And Intermediates Private Limited - Company Profile

It is a pharma private limited company based in Hyderabad, Telangana, India, established in 2006.
2006 Hyderabad, Telangana, India Active
Last Updated:
Access Report
About Total Drugs And Intermediates Private Limited

Total Drugs And Intermediates Private Limited, a active private limited company, was established on 02 February 2006 in Hyderabad, Telangana, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24222TG2006PTC048986. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹2.00 Cr and a paid-up capital of ₹1.00 Cr.

It upholds a compliant status. Employing 10 professional, Its leadership includes Narasimha Reddy Enukonda (Managing Director), Sunitha Sathi (Director), Alluru Ashokreddy (Director). Past directors included Rambabu Sathi, Anam Mahitha, Anam Hanuman Abhishek Reddy. It holds ₹5.90 Cr open charges and ₹13.78 Cr settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at S No 10 Gaddapotharam Jinnaram Mandal, Hyderabad, Telangana, 502319.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24222TG2006PTC048986

  • Registration Number

    048986

  • Incorporation Date

    02 February 2006

  • Authorized Capital

    ₹2.00 Cr

  • Paid-Up Capital

    ₹1.00 Cr

  • ROC Code

    Roc Hyderabad

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 2.00 Cr
  • Paid Up Capital ₹ 1.00 Cr
  • Company Age 20 Year, 22 Days
  • Last Filing with ROC 31 Mar 2025
  • Open Charges ₹ 5.90 Cr
  • Satisfied Charges ₹ 13.78 Cr
  • Revenue Growth **** 35.07%
  • Profit Growth **** -34.87%
  • Ebitda **** 11.12%
  • Net Worth 53.38%
  • Total Assets **** 21.25%
Company report

Total Drugs And Intermediates Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Total Drugs And Intermediates Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Total Drugs And Intermediates Private Limited?
Current Directors
Name Designation Appointment Date Status
Narasimha Reddy Enukonda Managing Director 01 Jul 2011 Current
Sunitha Sathi Director 22 Aug 2022 Current
Alluru Ashokreddy Director 01 Jul 2011 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 22 Jan 2021 Past
Pramod Abcsdd Director 01 Jul 2011 Past
Pramod Abcsdd Director 01 Mar 2012 Past
Pramod Abcsdd Director 01 Apr 2012 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Total Drugs And Intermediates.

Total Drugs And Intermediates Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 35.07% increase. The company also saw a substantial fall in profitability, with a 34.87% decrease in profit. The company's net worth Soared by an impressive increase of 53.38%.

Total Drugs And Intermediates revenue growth over time
Total Drugs And Intermediates profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 35.07%
*******
*******
*******
*******
Revenue from Operations
*******
 35.33%
*******
*******
*******
*******
Total Assets
*******
 21.25%
*******
*******
*******
*******
Profit or Loss
*******
 -34.87%
*******
*******
*******
*******
Net Worth
*******
 53.38%
*******
*******
*******
*******
EBITDA
*******
 11.12%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Total Drugs And Intermediates?

In 2023, Total Drugs And Intermediates had a public holding of 18.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹59,000,000.00

Satisfied Charges

₹137,800,000.00

Charges Breakdown by Lending Institutions
  • State Bank Of India : 5.90 Cr
Latest Charge Details
Date Lender Amount Status
10 Dec 2024 State Bank Of India ₹5.90 Cr Open
29 Sep 2022 Others ₹6.50 Cr Satisfied
20 May 2020 Others ₹5.00 Cr Satisfied
19 Mar 2012 Indian Overseas Bank ₹2.28 Cr Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Total Drugs And Intermediates?

Total Drugs And Intermediates has a workforce of 10 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Total Drugs And Intermediates, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Total Drugs And Intermediates's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Total Drugs And Intermediates
Recent Activity within the Organization
  • Annual General Meeting

    The activity Total Drugs And Intermediates Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was completed.

  • Balance Sheet

    Progress on Total Drugs And Intermediates Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad. was documented.

  • Charges

    A charge registered on 20 May 2020 via Charge ID 100354499 with Others was fully satisfied on 13 Jan 2025. was recorded as a recent event.

  • Charges

    The activity A charge with State Bank Of India amounted to Rs. 5.90 Cr with Charge ID 101023674 was registered on 10 Dec 2024. was completed.

  • Charges

    Progress on A charge registered on 29 Sep 2022 via Charge ID 100620470 with Others was fully satisfied on 05 Jul 2024. was documented.

  • Charges

    The activity A charge with Others of Rs. 5.00 Cr registered on 20 May 2020 with Charge ID 100354499 was modified on 02 Jan 2023. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Total Drugs And Intermediates Private Limited?

The CIN of Total Drugs And Intermediates Private Limited is U24222TG2006PTC048986.

Where is Total Drugs And Intermediates Private Limited headquartered?

Total Drugs And Intermediates Private Limited is headquartered at S No 10 Gaddapotharam Jinnaram Mandal, Hyderabad, Telangana, 502319.

When was Total Drugs And Intermediates Private Limited incorporated?

Total Drugs And Intermediates Private Limited was incorporated on 02 February 2006.

Who are the current directors of Total Drugs And Intermediates Private Limited?

The current directors of Total Drugs And Intermediates Private Limited are

What is the primary industry of Total Drugs And Intermediates Private Limited?

The primary industry of Total Drugs And Intermediates Private Limited is Manufacturing.

Is Total Drugs And Intermediates Private Limited a listed company?

Total Drugs And Intermediates Private Limited is unlisted.

What is the capital structure of Total Drugs And Intermediates Private Limited?

The authorized capital of Total Drugs And Intermediates Private Limited is ₹2.00 Cr, and the paid-up capital is ₹1.00 Cr.

What is the compliance status of Total Drugs And Intermediates Private Limited?

The compliance status of Total Drugs And Intermediates Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available